Stay updated on Semaglutide Effectiveness in Obesity Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Effectiveness in Obesity Clinical Trial page.

Latest updates to the Semaglutide Effectiveness in Obesity Clinical Trial page
- Check5 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and points visitors to updates and FAQs.SummaryDifference1%

- Check12 days agoChange DetectedThe ClinicalTrials.gov study page still displays a 403 Forbidden error, while the footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check19 days agoChange DetectedThe site footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check40 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating the study record is inaccessible. The previous study details and navigation are replaced by the error page.SummaryDifference19%

- Check47 days agoChange DetectedTel Litwinsky, Israel, 52621 was added to the study locations and Qiryat Krinitzi, Israel, 52621 was removed from the locations list. This update reflects changes to the trial's participating sites in Israel.SummaryDifference0.1%

- Check61 days agoChange DetectedIsrael site list updated: Qiryat Krinitzi, Israel, 52621 added; Tel Litwinsky, Israel, 52621 removed. Revision: v3.6.6 updated from v3.6.5.SummaryDifference0.1%

Stay in the know with updates to Semaglutide Effectiveness in Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Effectiveness in Obesity Clinical Trial page.